日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Nikon CeLL unveils Cell Therapy in Japan with RoosterBio
Nikon CeLL Innovation Co., Ltd. (NCLi), a subsidiary of Nikon Corporation, has…
Mediguru Raises ¥245M in Pre-Series A by XTech Ventures
Mediguru Inc., a company that provides a regional medical collaboration system, is…
Agatha Corporation acquires investment from ARCHIMED
Agatha Corporation, provider of the clinical trial/quality document management cloud system "Agatha",…
Kura Oncology, Kyowa Kirin Submit its Ziftomenib to FDA
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a…
B-EN-G Launches BatchLine Lite MES for Pharma Records
Business Engineering Co., Ltd. is pleased to announce that it has begun…
Artificial Intelligence and Mental Health, Can Tech Heal it?
In this tech-driven world, a key question arises: Can artificial intelligence, often…
New Chromatography Data Platform Wins Bio-IT World Award for Genmab and Genedata
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, announced…
DOCOMO and Ubie Form Strategic Capital and Business Alliance
NTT DOCOMO, INC., led by Representative Director and President Yoshiaki Maeda, is…
Latest Article
English